{"entity":{"type":"insider","cik":"0001734389","url":"/insider/0001734389","json_url":"/insider/0001734389.json","name":"Chin Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":9,"first":"2018-06-01","last":"2022-04-25","span_basis":"filed_date"},"name_variants":[{"name":"Chin Mark","source":"filing","n_filings":9,"first_seen":"2018-06-01","last_seen":"2022-04-25"}],"transactions":[{"id":6502430,"accession":"0000899243-22-015542","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-015542","line_url":"/filing/0000899243-22-015542#line-1","is_derivative":false,"issuer_cik":"0001734389","issuer_name":"Pyxis Oncology, Inc.","issuer_ticker":"PYXS","issuer_name_source":null,"issuer_url":"/issuer/0001734389","owner_cik":"0001734389","owner_name":"Chin Mark","owner_display_name":"Chin Mark","owner_url":"/insider/0001734389","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1745761.0,"shares_display":"1,745,761","price_per_share":3.05,"price_display":"3.05","price_state":"stated","total_value":5324571.05,"total_display":"5,324,571.05","total_whole":"5,324,571","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-21","filed_date":"2022-04-25","scope":"insider"},{"id":5542087,"accession":"0001140361-21-034645","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-21-034645","line_url":"/filing/0001140361-21-034645#line-2","is_derivative":false,"issuer_cik":"0001734389","issuer_name":"Pyxis Oncology, Inc.","issuer_ticker":"PYXS","issuer_name_source":null,"issuer_url":"/issuer/0001734389","owner_cik":"0001734389","owner_name":"Chin Mark","owner_display_name":"Chin Mark","owner_url":"/insider/0001734389","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":1745761.0,"shares_owned_after_display":"1,745,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-13","filed_date":"2021-10-15","scope":"insider"},{"id":4102568,"accession":"0001209191-21-048395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-048395","line_url":"/filing/0001209191-21-048395#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"IMARA Inc.","issuer_ticker":"IMRA","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001734389","owner_name":"Chin Mark","owner_display_name":"Chin Mark","owner_url":"/insider/0001734389","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1333333.0,"shares_display":"1,333,333","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":7999998.0,"total_display":"7,999,998.00","total_whole":"7,999,998","shares_owned_after":2344072.0,"shares_owned_after_display":"2,344,072","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-16","filed_date":"2021-07-28","scope":"insider"},{"id":3238751,"accession":"0000899243-20-008490","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-008490","line_url":"/filing/0000899243-20-008490#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"IMARA Inc.","issuer_ticker":"IMRA","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001734389","owner_name":"Chin Mark","owner_display_name":"Chin Mark","owner_url":"/insider/0001734389","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":1554558.0,"shares_owned_after_display":"1,554,558","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-16","scope":"insider"},{"id":8420425,"accession":"0001209191-19-061059","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-061059","line_url":"/filing/0001209191-19-061059#line-3","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001734389","owner_name":"Chin Mark","owner_display_name":"Chin Mark","owner_url":"/insider/0001734389","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12476.0,"shares_display":"12,476","price_per_share":16.8298,"price_display":"16.83","price_state":"stated","total_value":209968.5848,"total_display":"209,968.58","total_whole":"209,969","shares_owned_after":2572359.0,"shares_owned_after_display":"2,572,359","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-17","filed_date":"2019-12-17","scope":"insider"},{"id":8420423,"accession":"0001209191-19-061059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-061059","line_url":"/filing/0001209191-19-061059#line-2","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001734389","owner_name":"Chin Mark","owner_display_name":"Chin Mark","owner_url":"/insider/0001734389","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13080.0,"shares_display":"13,080","price_per_share":17.0245,"price_display":"17.02","price_state":"stated","total_value":222680.46,"total_display":"222,680.46","total_whole":"222,680","shares_owned_after":2584835.0,"shares_owned_after_display":"2,584,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-16","filed_date":"2019-12-17","scope":"insider"},{"id":8420418,"accession":"0001209191-19-061059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-061059","line_url":"/filing/0001209191-19-061059#line-1","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001734389","owner_name":"Chin Mark","owner_display_name":"Chin Mark","owner_url":"/insider/0001734389","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11002.0,"shares_display":"11,002","price_per_share":17.2097,"price_display":"17.21","price_state":"stated","total_value":189341.1194,"total_display":"189,341.12","total_whole":"189,341","shares_owned_after":2597915.0,"shares_owned_after_display":"2,597,915","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-13","filed_date":"2019-12-17","scope":"insider"},{"id":8760339,"accession":"0001209191-19-059954","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-059954","line_url":"/filing/0001209191-19-059954#line-4","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001734389","owner_name":"Chin Mark","owner_display_name":"Chin Mark","owner_url":"/insider/0001734389","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131696.0,"shares_display":"131,696","price_per_share":16.9103,"price_display":"16.91","price_state":"stated","total_value":2227018.8688,"total_display":"2,227,018.87","total_whole":"2,227,019","shares_owned_after":2608917.0,"shares_owned_after_display":"2,608,917","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-10","scope":"insider"},{"id":8760336,"accession":"0001209191-19-059954","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-059954","line_url":"/filing/0001209191-19-059954","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001734389","owner_name":"Chin Mark","owner_display_name":"Chin Mark","owner_url":"/insider/0001734389","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103754.0,"shares_display":"103,754","price_per_share":18.162629086107522,"price_display":"18.16","price_state":"stated","total_value":1884445.4182,"total_display":"1,884,445.42","total_whole":"1,884,445","shares_owned_after":2740613.0,"shares_owned_after_display":"2,740,613","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider","n_lines":2},{"id":8760330,"accession":"0001209191-19-059954","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-059954","line_url":"/filing/0001209191-19-059954#line-1","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001734389","owner_name":"Chin Mark","owner_display_name":"Chin Mark","owner_url":"/insider/0001734389","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47752.0,"shares_display":"47,752","price_per_share":19.1452,"price_display":"19.15","price_state":"stated","total_value":914221.5904,"total_display":"914,221.59","total_whole":"914,222","shares_owned_after":2844367.0,"shares_owned_after_display":"2,844,367","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-06","filed_date":"2019-12-10","scope":"insider"},{"id":8511766,"accession":"0001209191-19-010297","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-010297","line_url":"/filing/0001209191-19-010297#line-3","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001734389","owner_name":"Chin Mark","owner_display_name":"Chin Mark","owner_url":"/insider/0001734389","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":428571.0,"shares_display":"428,571","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":5999994.0,"total_display":"5,999,994.00","total_whole":"5,999,994","shares_owned_after":2892119.0,"shares_owned_after_display":"2,892,119","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-12","filed_date":"2019-02-14","scope":"insider"},{"id":6498644,"accession":"0001209191-18-056808","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-056808","line_url":"/filing/0001209191-18-056808#line-1","is_derivative":false,"issuer_cik":"0001659323","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001659323","owner_cik":"0001734389","owner_name":"Chin Mark","owner_display_name":"Chin Mark","owner_url":"/insider/0001734389","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58000.0,"shares_display":"58,000","price_per_share":6.1,"price_display":"6.10","price_state":"stated","total_value":353800.0,"total_display":"353,800.00","total_whole":"353,800","shares_owned_after":1089903.0,"shares_owned_after_display":"1,089,903","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-30","filed_date":"2018-11-01","scope":"insider"},{"id":6585299,"accession":"0001209191-18-034622","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-034622","line_url":"/filing/0001209191-18-034622#line-3","is_derivative":false,"issuer_cik":"0001659323","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001659323","owner_cik":"0001734389","owner_name":"Chin Mark","owner_display_name":"Chin Mark","owner_url":"/insider/0001734389","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":337606.0,"shares_display":"337,606","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":4388878.0,"total_display":"4,388,878.00","total_whole":"4,388,878","shares_owned_after":1031903.0,"shares_owned_after_display":"1,031,903","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-06-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001782223","name":"Pyxis Oncology, Inc.","url":"/issuer/0001782223","role":"Director, Other","n_filings":2,"first_seen":"2021-10-15","last_seen":"2022-04-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"IMARA Inc.","url":"/issuer/0001672619","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2020-03-16","last_seen":"2021-07-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001708493","name":"Harpoon Therapeutics, Inc.","url":"/issuer/0001708493","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2019-02-14","last_seen":"2019-12-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001659323","name":"Iterum Therapeutics plc","url":"/issuer/0001659323","role":"Director","n_filings":2,"first_seen":"2018-06-01","last_seen":"2018-11-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001734389","retrieved_at":"2026-08-26T10:17:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}